Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.

Q4 2024 Earnings Call Transcript March 11, 2025 Agenus Inc. beats earnings expectations. Reported EPS is $-2.04, expectations ...

Baird lowered the firm’s price target on Agenus (AGEN) to $3 from $6 and keeps a Neutral rating on the shares. The firm updated its model ...

Agenus Inc (AGEN) reports reduced operational burn and promising clinical developments, despite a significant net loss and ...

Good morning, and welcome to Agenus Inc.'s fourth-quarter and year-end 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded. I will now turn the call ...